Randomized trial analyzes genomic features of carbapenem-resistant Klebsiella pneumoniae, indicating heightened virulence and resistance mechanisms.
OBJECTIVES: The global convergence of multidrug resistance and hypervirulence in Klebsiella pneumoniae poses a critical public health threat. While ST11-KL64 has historically dominated in China, the evolutionary dynamics driving the emergence of novel high-risk sublineages remain poorly understood. METHODS: We analysed 304 non-duplicate carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates collected in Zhejiang Province, China, during 2024-2025 using antimicrobial susceptibility testing, whole-genome sequencing, plasmid analysis, and phylogenetic reconstruction. Publicly available genomes were incorporated for comparative genomic and phylogenetic analyses. RESULTS: were linked to IncFII(pHN7A8)-IncR-like and IncN-like plasmids, respectively. Correlation analyses demonstrated coordinated accumulation of resistance and virulence determinants specifically in rmpA-intact ST11-KL19 isolates. In the global ST11-KL19 phylogeny, the C2e subcluster showed a higher burden of antimicrobial resistance genes and hypervirulence-associated markers than other subclusters. CONCLUSIONS: ST11-KL19 represents a CRKP background with increased local detection and frequent carriage of dual carbapenemases, hypervirulence-associated markers, and resistance to last-line agents. These findings support enhanced genomic surveillance of ST11-KL19, while multicentre longitudinal studies and functional assays are required to define its transmissibility, virulence phenotype, and evolutionary trajectory.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: